Lenskart investor Epiq Capital’s Fund II oversubscribed at $225 million

Venture capital firm Epiq Capital on Wednesday said announced raising USD 225 million under its Fund II which would invest a major part of the proceeds in technology start-ups.

The company is an investor in unicorns such as Lenskart, Pristyn Care, Cure.fit, Dailyhunt and Builder.ai.

“Epiq Capital II has been oversubscribed at USD 225 million,” Epiq Capital, Founder and Managing Partner, Rishi Navani said. Epiq Capital had set a target to raise USD 200 million for Fund II. It plans to invest a major portion of the Fund II in technology start-ups.